Eastern Bank’s Collegium Pharmaceutical COLL Stock Holding History

Eastern Bank’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99M	Hold	54,843	–	–	0.03%	162
2026 Q1	$1.81M	Hold	54,843	–	–	0.03%	175
2025 Q4	$2.54M	Hold	54,843	–	–	0.04%	134
2025 Q3	$1.92M	Buy	54,843 +45,508	+487%	+$1.58M	0.03%	148
2025 Q2	$276K	Hold	9,335	–	–	0.01%	316
2025 Q1	$279K	Hold	9,335	–	–	0.01%	317
2024 Q4	$267K	Hold	9,335	–	–	0.01%	328
2024 Q3	$361K	Hold	9,335	–	–	0.01%	315
2024 Q2	$301K	Hold	9,335	–	–	0.01%	174
2024 Q1	$362K	Hold	9,335	–	–	0.02%	173
2023 Q4	$287K	Hold	9,335	–	–	0.01%	185
2023 Q3	$209K	Hold	9,335	–	–	0.01%	196
2023 Q2	$201K	Hold	9,335	–	–	0.01%	198
2023 Q1	$224K	Hold	9,335	–	–	0.01%	187
2022 Q4	$217K	Buy	+9,335	New	+$188K	0.01%	195
2021 Q3	–	Sell	-9,335	Closed	-$221K	–	188
2021 Q2	$221K	Hold	9,335	–	–	0.01%	182
2021 Q1	$221K	Buy	+9,335	New	+$222K	0.01%	177

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Eastern Bank's COLL Position: Q2 2026 in Review

Eastern Bank held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 54,843 shares worth $1.99M. The position accounts for 0.03% of the portfolio, ranked #162.

Eastern Bank first reported a position in COLL in Q1 2021 and has held it in 17 quarters since. The position peaked at $2.54M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Eastern Bank held 54,843 shares of Collegium Pharmaceutical worth $1.99M as of Q2 2026.
Eastern Bank left its Collegium Pharmaceutical share count unchanged in Q2 2026.
Collegium Pharmaceutical made up 0.03% of Eastern Bank's portfolio in Q2 2026, its #162 holding.
Eastern Bank first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 17 quarters since.
Eastern Bank's Collegium Pharmaceutical position peaked at $2.54M in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.